Adoptive cell transfer with chimeric antigen receptor (CAR)-expressing T cells can induce remarkable complete responses in ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

11月27日，中南大学湘雅二医院血液内科彭宏凌教授团队在国际权威期刊Journal of Clinical Investigation（IF=19.4）发表了题为《IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cells》的原创性研究论文 ...

T cells and allogeneic hematopoietic stem cell transplantation. Dr Simonetta's clinical work is mainly focused on Chimeric ...

Preclinical studies showed that the addition of IL-15 could improve the performance of CAR T cell-based immunotherapies.

By Priyanjana Pramanik, MSc. IL-15 enhances the growth and survival of GPC3 CAR T cells, improving their ability to target ...

TUESDAY, Dec. 3, 2024 (HealthDay News) -- A newly approved immunotherapy can help adults with a difficult-to-treat form of ...

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

A new chimeric antigen receptor T cell (CAR-T) therapy has delivered promising results in treating patients with an ...

11月27日，国际学术期刊Immunity在线发表了中国科学院分子细胞科学卓越创新中心 (生物化学与细胞生物学研究所)许琛琦研究组联合上海科技大学王皞鹏研究组的最新合作成果：“Phase?separation of chimeric antigen receptor promotes immunological synapse?maturation and ...